Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

670
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
670
Tissue Transplantation01:24

Tissue Transplantation

1.2K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

733
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
733
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

534
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
534

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter to the Editor: Is the SRTR metric "Survival on the Waitlist" still useful in the age of machine perfusion and short liver transplant wait times?

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2025
Same author

Germline Variants Influence Chronic Liver Disease Progression through Distinct Pathways.

medRxiv : the preprint server for health sciences·2025
Same author

The Dallas Donation after Circulatory Death Transplantation Summit: expanding donation after circulatory death procedures through process improvement, broader utilization, and innovation.

Hepatobiliary surgery and nutrition·2024
Same author

Prospective evaluation of cystatin C in the assessment of kidney dysfunction and survival in liver transplant candidates.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2024
Same author

A cost comparison of liver acquisition fees for donation after circulatory death versus donation after brain death donors.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2024
Same author

Policy Corner: HCC exception update.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2023
Same journal

Update on the Management of Pregnant Patients With Inflammatory Bowel Disease.

Gastroenterology & hepatology·2026
Same journal

Management of Granulomatous Hepatitis.

Gastroenterology & hepatology·2026
Same journal

Update on Pregnancy in Inflammatory Bowel Disease.

Gastroenterology & hepatology·2026
Same journal

Strategies for Improving Hepatocellular Carcinoma Surveillance Rates.

Gastroenterology & hepatology·2026
Same journal

Managing the Diagnostic and Therapeutic Challenges of Irritable Bowel Syndrome.

Gastroenterology & hepatology·2026
Same journal

Raising the Bar on Risk Reduction in Post-ERCP Pancreatitis Prevention.

Gastroenterology & hepatology·2026
See all related articles

Related Experiment Video

Updated: Mar 20, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

8.5K

Current Issues in Liver Transplantation.

James F Trotter1

  • 1Dr Trotter is the medical director of liver transplantation at Baylor University Medical Center in Dallas, Texas.

Gastroenterology & Hepatology
|May 28, 2016
PubMed
Summary
This summary is machine-generated.

Liver transplant allocation may change to improve access nationwide. New direct-acting antiviral agents offer high cure rates for hepatitis C virus (HCV), improving patient and graft survival. Donor-specific antibodies (DSAs) are increasingly recognized in liver transplant rejection.

Keywords:
Liver transplantationantibody-mediated rejectionhepatitis Cliver allocation

More Related Videos

Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts
09:29

Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts

Published on: August 13, 2014

15.8K
Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
11:25

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

969

Related Experiment Videos

Last Updated: Mar 20, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

8.5K
Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts
09:29

Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts

Published on: August 13, 2014

15.8K
Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
11:25

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

969

Area of Science:

  • Hepatology and Transplant Surgery
  • Immunology and Infectious Diseases

Background:

  • Liver transplantation is a critical therapy for end-stage liver disease.
  • Significant advancements are reshaping the field, including organ allocation, viral hepatitis treatment, and rejection monitoring.

Purpose of the Study:

  • To review key evolving issues in liver transplantation.
  • To discuss proposed changes in donor liver allocation.
  • To highlight the impact of direct-acting antiviral agents for hepatitis C virus (HCV) and the role of donor-specific antibodies (DSAs) in rejection.

Main Methods:

  • Review of current literature and proposed policy changes.
  • Analysis of the clinical impact of direct-acting antiviral agents on HCV.
  • Examination of the role of donor-specific antibodies (DSAs) in liver transplant outcomes.

Main Results:

  • A proposal to expand geographic liver allocation aims to equalize access but faces controversy.
  • Direct-acting antiviral agents achieve high cure rates for HCV, promising improved outcomes for transplant candidates and recipients.
  • Donor-specific antibodies (DSAs) are emerging as significant predictors of graft and patient survival in liver transplantation, though therapeutic options remain limited.

Conclusions:

  • The field of liver transplantation is dynamic, with ongoing debates in organ allocation.
  • Direct-acting antiviral therapies represent a major breakthrough, significantly improving the prognosis for HCV-infected patients.
  • Further research is needed to clarify the role and management of DSAs in liver transplant rejection to optimize long-term graft survival.